Lexicon Pharmaceuticals
Lexicon Pharmaceuticals

Financials • Lexicon Pharmaceuticals

LXRX

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year
12/2016
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2017
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2018
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2019
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2020
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2021
0
-87
-12
L
L
114
L
-87
-
-98
-1
23
-99
-3
0
-
-
12/2022
0
-100
-123
L
L
117
L
-90
-
-100
-1
142
-102
-1
0
-
-
12/2023
1
-171
-123
L
L
93
L
-71
-
-176
-0
188
-177
-1
0
-
-
12/2024
31
-197
-123
L
L
146
L
-138
-
-192
-1
238
-193
-2
0
-
-
12/2025
50
-48
-12
L
L
108
L
-47
-
-80
0
-48
-80
-1
0
-
-

To see all financials—including updated, you must be Premium.